our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 16 April 2015

    Antares Pharma Announces Settlement of Patent Infringement Lawsuits
  • 31 March 2015

    Antares Pharma Announces FDA Approval of TEV-TROPIN 10 mg (Human Growth Hormone) Needle-Free Injector
  • 12 March 2015

    Antares Pharma Reports Fourth Quarter and Full Year 2014 Operating and Financial Results
  • 5 March 2015

    Antares Pharma To Host Fourth Quarter 2014 Operating and Financial Results Call
  • 25 February 2015

    Antares Pharma Announces Positive Top-line Pharmakcokinetic Results From the Quickshot Phase 3 Study in Testosterone Deficient Men
  • 23 February 2015

    Antares Pharma to Present at the Cowen and Company 35th Annual Healthcare Conference

latest products & technology


Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>